Download Files:
Secukinumab
Price range: 235 CAD through 1,744 CAD
Products Details
Product Description
– Secukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the treatment of moderate to severe plaque psoriasis.
Web ID
– T9930
Storage Temperature
– -20℃
Shipping
– Blue Ice
References
– Frieder J, et al.Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis.Ther Adv Chronic Dis. 2018 Jan;9(1):5-21.
CAS Number
– 1229022-83-6
Molecular Weight
Compound Purity
– 97.4% (SDS-PAGE); 98.3% (SEC-HPLC)
Pathway
– Immunology/Inflammation
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
